Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-23-020075

See Remarks sold 4,066 shares at $1.35 ($5,489)

  • See Remarks acquired 11,361 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ege David S. See Remarks 2023-10-27 Option exercise 10b5-1 +11,361 71,057 D: show line 1 in the form
Ege David S. See Remarks 2023-10-30 Sale 10b5-1 −4,066 $1.35 $5,489 66,991 D: show line 2 in the form
Open-market sales · 4,066 sh · avg $1.35 · $5,489

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ege David S. See Remarks 2023-04-27 Grant or award · Restricted Stock Units 10b5-1 +22,721 22,721 D: show line 3 in the form
Ege David S. See Remarks 2023-10-27 Option exercise · Restricted Stock Units 10b5-1 −11,361 11,360 D: show line 4 in the form
Loading xslF345X05/doc4.xml…